nodes	percent_of_prediction	percent_of_DWPC	metapath
Lercanidipine—Serum creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.0305	0.0309	CcSEcCtD
Lercanidipine—Peptic ulcer—Hydrochlorothiazide—nephrolithiasis	0.028	0.0285	CcSEcCtD
Lercanidipine—Feeling hot—Hydrochlorothiazide—nephrolithiasis	0.0239	0.0242	CcSEcCtD
Lercanidipine—Gamma-glutamyltransferase increased—Hydrochlorothiazide—nephrolithiasis	0.0228	0.0231	CcSEcCtD
Lercanidipine—Nocturia—Hydrochlorothiazide—nephrolithiasis	0.0202	0.0205	CcSEcCtD
Lercanidipine—Hypercholesterolaemia—Hydrochlorothiazide—nephrolithiasis	0.0198	0.0201	CcSEcCtD
Lercanidipine—Vasculitis—Hydrochlorothiazide—nephrolithiasis	0.0192	0.0195	CcSEcCtD
Lercanidipine—Hyperkalaemia—Hydrochlorothiazide—nephrolithiasis	0.0184	0.0187	CcSEcCtD
Lercanidipine—Blood urea increased—Hydrochlorothiazide—nephrolithiasis	0.0177	0.018	CcSEcCtD
Lercanidipine—Urine output increased—Hydrochlorothiazide—nephrolithiasis	0.0169	0.0172	CcSEcCtD
Lercanidipine—Sleep disorder—Hydrochlorothiazide—nephrolithiasis	0.0157	0.016	CcSEcCtD
Lercanidipine—Diabetes mellitus—Hydrochlorothiazide—nephrolithiasis	0.0156	0.0159	CcSEcCtD
Lercanidipine—Polyuria—Hydrochlorothiazide—nephrolithiasis	0.0155	0.0157	CcSEcCtD
Lercanidipine—Photosensitivity—Hydrochlorothiazide—nephrolithiasis	0.0155	0.0157	CcSEcCtD
Lercanidipine—Nicardipine—CHRM3—nephrolithiasis	0.0155	1	CrCbGaD
Lercanidipine—Dermatitis exfoliative—Hydrochlorothiazide—nephrolithiasis	0.0144	0.0146	CcSEcCtD
Lercanidipine—Arthritis—Hydrochlorothiazide—nephrolithiasis	0.014	0.0142	CcSEcCtD
Lercanidipine—Hyponatraemia—Hydrochlorothiazide—nephrolithiasis	0.0137	0.0139	CcSEcCtD
Lercanidipine—Migraine—Hydrochlorothiazide—nephrolithiasis	0.0134	0.0136	CcSEcCtD
Lercanidipine—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.0131	0.0133	CcSEcCtD
Lercanidipine—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.0127	0.0129	CcSEcCtD
Lercanidipine—Orthostatic hypotension—Hydrochlorothiazide—nephrolithiasis	0.0124	0.0126	CcSEcCtD
Lercanidipine—Abdominal pain upper—Hydrochlorothiazide—nephrolithiasis	0.0124	0.0126	CcSEcCtD
Lercanidipine—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.0123	0.0125	CcSEcCtD
Lercanidipine—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.0122	0.0124	CcSEcCtD
Lercanidipine—Toxic epidermal necrolysis—Hydrochlorothiazide—nephrolithiasis	0.0122	0.0124	CcSEcCtD
Lercanidipine—Aspartate aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.0122	0.0124	CcSEcCtD
Lercanidipine—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.012	0.0122	CcSEcCtD
Lercanidipine—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.012	0.0122	CcSEcCtD
Lercanidipine—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.0115	0.0117	CcSEcCtD
Lercanidipine—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.0114	0.0116	CcSEcCtD
Lercanidipine—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.011	0.0112	CcSEcCtD
Lercanidipine—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.0109	0.011	CcSEcCtD
Lercanidipine—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.0108	0.011	CcSEcCtD
Lercanidipine—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.0107	0.0109	CcSEcCtD
Lercanidipine—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.0104	0.0106	CcSEcCtD
Lercanidipine—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.0103	0.0105	CcSEcCtD
Lercanidipine—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.0103	0.0105	CcSEcCtD
Lercanidipine—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.0103	0.0104	CcSEcCtD
Lercanidipine—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.0103	0.0104	CcSEcCtD
Lercanidipine—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.0102	0.0104	CcSEcCtD
Lercanidipine—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.00978	0.00993	CcSEcCtD
Lercanidipine—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.00943	0.00958	CcSEcCtD
Lercanidipine—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.00941	0.00955	CcSEcCtD
Lercanidipine—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.00927	0.00941	CcSEcCtD
Lercanidipine—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.00889	0.00903	CcSEcCtD
Lercanidipine—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00877	0.00891	CcSEcCtD
Lercanidipine—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00873	0.00887	CcSEcCtD
Lercanidipine—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00831	0.00844	CcSEcCtD
Lercanidipine—Erythema—Hydrochlorothiazide—nephrolithiasis	0.00819	0.00832	CcSEcCtD
Lercanidipine—Tension—Hydrochlorothiazide—nephrolithiasis	0.00804	0.00816	CcSEcCtD
Lercanidipine—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00802	0.00814	CcSEcCtD
Lercanidipine—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00795	0.00808	CcSEcCtD
Lercanidipine—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00787	0.008	CcSEcCtD
Lercanidipine—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00772	0.00784	CcSEcCtD
Lercanidipine—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.0076	0.00772	CcSEcCtD
Lercanidipine—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00757	0.00769	CcSEcCtD
Lercanidipine—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00748	0.0076	CcSEcCtD
Lercanidipine—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00738	0.0075	CcSEcCtD
Lercanidipine—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00736	0.00747	CcSEcCtD
Lercanidipine—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00734	0.00746	CcSEcCtD
Lercanidipine—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00724	0.00735	CcSEcCtD
Lercanidipine—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.0072	0.00731	CcSEcCtD
Lercanidipine—Cough—Hydrochlorothiazide—nephrolithiasis	0.00715	0.00726	CcSEcCtD
Lercanidipine—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00697	0.00708	CcSEcCtD
Lercanidipine—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00697	0.00708	CcSEcCtD
Lercanidipine—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00697	0.00708	CcSEcCtD
Lercanidipine—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00695	0.00706	CcSEcCtD
Lercanidipine—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00689	0.007	CcSEcCtD
Lercanidipine—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00682	0.00692	CcSEcCtD
Lercanidipine—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00674	0.00684	CcSEcCtD
Lercanidipine—Shock—Hydrochlorothiazide—nephrolithiasis	0.00657	0.00668	CcSEcCtD
Lercanidipine—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00654	0.00665	CcSEcCtD
Lercanidipine—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00652	0.00662	CcSEcCtD
Lercanidipine—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00646	0.00656	CcSEcCtD
Lercanidipine—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00637	0.00647	CcSEcCtD
Lercanidipine—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00624	0.00634	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00609	0.00618	CcSEcCtD
Lercanidipine—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00604	0.00614	CcSEcCtD
Lercanidipine—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.006	0.0061	CcSEcCtD
Lercanidipine—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00596	0.00605	CcSEcCtD
Lercanidipine—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00594	0.00603	CcSEcCtD
Lercanidipine—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00588	0.00598	CcSEcCtD
Lercanidipine—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00581	0.0059	CcSEcCtD
Lercanidipine—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00576	0.00585	CcSEcCtD
Lercanidipine—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00571	0.0058	CcSEcCtD
Lercanidipine—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00551	0.00559	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00546	0.00555	CcSEcCtD
Lercanidipine—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00531	0.00539	CcSEcCtD
Lercanidipine—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00528	0.00537	CcSEcCtD
Lercanidipine—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00528	0.00537	CcSEcCtD
Lercanidipine—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00492	0.005	CcSEcCtD
Lercanidipine—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00479	0.00487	CcSEcCtD
Lercanidipine—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00473	0.0048	CcSEcCtD
Lercanidipine—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00457	0.00464	CcSEcCtD
Lercanidipine—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00442	0.00449	CcSEcCtD
Lercanidipine—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00425	0.00432	CcSEcCtD
Lercanidipine—Rash—Hydrochlorothiazide—nephrolithiasis	0.00421	0.00428	CcSEcCtD
Lercanidipine—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00421	0.00428	CcSEcCtD
Lercanidipine—Headache—Hydrochlorothiazide—nephrolithiasis	0.00419	0.00425	CcSEcCtD
Lercanidipine—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00397	0.00403	CcSEcCtD
